Home/Filings/4/0001193125-25-280126
4//SEC Filing

Ganot Ilan 4

Accession 0001193125-25-280126

CIK 0001707502other

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 4:05 PM ET

Size

6.9 KB

Accession

0001193125-25-280126

Insider Transaction Report

Form 4
Period: 2025-11-10
Ganot Ilan
Director
Transactions
  • Sale

    Common Stock

    2025-11-10$4.12/sh3,278$13,50595,412 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    19,394
  • Common Stock

    (indirect: By Spouse)
    14,839
Footnotes (3)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.11 to $4.12, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form.
  • [F2]Represents 91,370 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.
  • [F3]Represents 19,394 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.

Documents

1 file

Issuer

Solid Biosciences Inc.

CIK 0001707502

Entity typeother

Related Parties

1
  • filerCIK 0001727460

Filing Metadata

Form type
4
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 4:05 PM ET
Size
6.9 KB